Heroin Addiction Treatment Correlates in Maryland
March 12, 2007
This is the first report in a series commissioned by the Baltimore City Health Department exploring whether the expansion of buprenorphine as a strategy for battling opioid addiction is cost-effective. This report uses Medicaid data to examine health care service utilization differences between opioid addicts who were treated for this condition versus addicts who were not.
Also in this series of reports are: Review of Cost-Benefit and Cost-Effectiveness Literature for Methadone or Buprenorphine as a Treatment for Opiate Addiction; Opioid Exposure in Maryland Hospitals; Comparing Pre-Treatment to Post-Treatment Medicaid Utilization in Individuals Who Enter Methadone Therapy; and An Evaluation of Whether Medical Savings are Associated with Expanding Opioid Maintenance Therapy for Heroin Addiction in Baltimore City.